DrugPatentWatch Database Preview
Profile for European Patent Office Patent: 0806968
» See Plans and Pricing
Country | SPC | SPC Expiration |
---|---|---|
France | 07C0028 | Start Trial |
Netherlands | 300253 | Start Trial |
Switzerland | C00806968/01 | Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 0806968
US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
---|---|---|---|---|
Start Trial | May 4, 2020 | Lantheus Medcl | ABLAVAR | gadofosveset trisodium |
>US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |